William Febbo | CEO |
Doug Baker | CFO |
Miriam Paramore | President |
Eric Martinuzzi | Lake Street Capital Markets |
Richard Baldry | ROTH Capital |
Andrew D'Silva | B. Riley FBR |
Harvey Poppel | PopTech |
Good afternoon, and thank you for joining us today to discuss OptimizeRx Second Quarter ended June 30, 2018. With us are the company's Chief Executive Officer, William Febbo; company President, Miriam Paramore; and Chief Financial Officer, Doug Baker.
Following their remarks, we'll open your call to questions. Then before we conclude today's call, I'll provide some important cautions regarding the forward-looking statements made by management during the call. I'd also like to remind everyone that today's call is being recorded and will be made available for telephone replay via instructions in today's press release in the investor's section of the company's website.